Country: Israel
Language: English
Source: Ministry of Health
DEXTROSE ANHYDROUS; SODIUM CHLORIDE
ELDAN ELECTRONIC INSTRUMENTS CO LTD, ISRAEL
B05XA03
SOLUTION FOR INFUSION
DEXTROSE ANHYDROUS 4.3 %W/V; SODIUM CHLORIDE 0.18 %W/V
I.V
Required
VIOSER S.A. PARENTERAL SOLUTIONS INDUSTRY, GREECE
SODIUM CHLORIDE
DEXTROSE 4.3 % AND 0.18 % SODIUM CHLORIDE VIOSER solution is used in the following indications: Dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, over use ofdiuretics) in cases where a source of energy is required (particularly starvation). Paediatric Population: This product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, high dependency units and intensive care units) for intravenous fluid therapy requiring the use of 0.18% sodium chloride and4% glucose to maintain fluid and electrolyte balance.
2022-12-18
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT DEXTROSE 4.3 % AND 0.18 % SODIUM CHLORIDE VIOSER, SOLUTION FOR INFUSION 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1000ml solution contains: Sodium Chloride: 1.8 g Dextrose anhydrous: 43.0 g Each ml contains 1.8 mg sodium chloride and 43 mg dextrose anhydrous. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear and colorless aqueous solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dextrose 4.3 % and 0.18 % sodium chloride Vioser solution is used in the following indications: Dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, overuse of diuretics) in cases where a source of energy is required (particularly starvation). Paediatric Population: This product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, high dependency units and intensive care units) for intravenous fluid therapy requiring the use of dextrose 4.3 % and 0.18 % sodium chloride to maintain fluid and electrolyte balance. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The choice of the specific sodium chloride and dextrose (glucose) concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician. For patients with electrolyte and glucose abnormalities and for paediatric patients, consult a physician experienced in intravenous fluid therapy. Fluid balance, serum glucose, serum sodium and other electrolytes should be monitored before and during administration, especially in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs due to the risk of hyponatraemia. Monitoring of serum sodium is particularly important for physiologically hypotonic fluids. Dextrose 4.3 % w/v and so Read the complete document